YDOV-157Homo sapiens (Human)Cancer cell line

Also known as: YongDong OVarian-157

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_W954
SpeciesHomo sapiens (Human)
Tissue SourceAscites[UBERON:UBERON_0007795]

Disease Information

DiseaseOvarian serous adenocarcinoma

DepMap Information

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
9
D3S1358
15,16
D5S818
11,13
D7S820
10,11
FGA
20,23
TH01
8,9
TPOX
12
vWA
17

Publications

ALDH1A2 is a candidate tumor suppressor gene in ovarian cancer.";

Choi J.-A., Kwon H., Cho H., Chung J.-Y., Hewitt S.M., Kim J.-H.

Cancers (Basel) 11:1553.1-1553.18(2019).

Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer.

Cho H., Lee Y.S., Kim J., Chung J.-Y., Kim J.-H.

Cancer Invest. 31:607-615(2013).

ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139.

Kim Y.T., Kim J.-H.

Int. J. Oncol. 37:399-412(2010).

Genomic and proteomic characterization of YDOV-157, a newly established human epithelial ovarian cancer cell line.

Kim Y.T., Lee K.S., Choi Y.K., Kim J.-H.

Mol. Cell. Biochem. 319:189-201(2008).

Lipocalin2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer.

Cho H., Kim J.-H.

J. Histochem. Cytochem. 57:513-521(2009).